• LAST PRICE
    2.2100
  • TODAY'S CHANGE (%)
    Trending Up0.1700 (8.3333%)
  • Bid / Lots
    2.0800/ 2
  • Ask / Lots
    2.6300/ 1
  • Open / Previous Close
    2.1000 / 2.0400
  • Day Range
    Low 2.0500
    High 2.3299
  • 52 Week Range
    Low 1.5400
    High 16.2100
  • Volume
    29,991
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 2.04
TimeVolumeTFFP
09:52 ET19002.1496
09:54 ET1002.05
10:01 ET2002.14
10:08 ET4512.1
10:17 ET1502.1175
10:42 ET1002.095
10:44 ET11002.13
10:48 ET1002.105
10:57 ET1002.105
11:06 ET5002.1
11:09 ET13002.1
11:11 ET1002.1
11:20 ET1002.095
11:58 ET14102.109
12:00 ET1002.145
12:07 ET1002.145
12:25 ET2502.145
12:30 ET1002.145
12:45 ET12002.1799
01:01 ET11002.145
01:03 ET1002.145
01:14 ET1002.145
01:46 ET5002.165
01:51 ET1002.165
01:53 ET2002.17
02:11 ET47002.23
02:18 ET7502.297
02:20 ET4002.256
02:22 ET21262.1
02:29 ET3002.11
02:33 ET1002.3
02:47 ET4172.15
02:51 ET2502.1616
02:56 ET2002.21
03:00 ET8002.23
03:02 ET50862.14
03:03 ET2002.0826
03:34 ET5002.17
03:45 ET1002.1258
03:48 ET2002.21
03:50 ET2712.1223
03:54 ET2002.1293
03:59 ET2002.21
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTFFP
TFF Pharmaceuticals Inc
6.8M
-0.2x
---
United StatesLGVN
Longeveron Inc
7.0M
-0.1x
---
United StatesAZTR
Azitra Inc
5.5M
-0.1x
---
United StatesSNGX
Soligenix Inc
5.8M
-0.5x
---
United StatesBDRX
Biodexa Pharmaceuticals PLC
4.5M
0.0x
---
United StatesVCNX
Vaccinex Inc
8.6M
-0.1x
---
As of 2024-05-26

Company Information

TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaging patented rapid freezing technology to develop and transform medicine into potent dry powder. It is focused on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform. Its TFF technology platform has an applicability to convert any drug, including vaccines, small and large molecules, and biologics, into a dry powder for inhalation, or for topical delivery to the eyes, nose and the skin. TFF Pharmaceuticals has two lead drug candidates in the clinic: TFF TAC (Tacrolimus Inhalation Powder) and TFF VORI (Voriconazole Inhalation Powder). TFF TAC is an inhaled dry powder formulation of tacrolimus, for the prophylaxis of organ rejection in patients receiving lung transplants, in combination with other immunosuppressants. TFF VORI is an inhaled dry powder formulation of voriconazole, for the treatment and prophylaxis of invasive pulmonary aspergillosis.

Contact Information

Headquarters
2600 Via Fortuna Ste 360AUSTIN, TX, United States 78746-7983
Phone
---
Fax
302-655-5049

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$6.8M
Revenue (TTM)
$885.7K
Shares Outstanding
3.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.39
EPS
$-10.20
Book Value
$4.04
P/E Ratio
-0.2x
Price/Sales (TTM)
7.7
Price/Cash Flow (TTM)
---
Operating Margin
-2,325.72%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.